172 related articles for article (PubMed ID: 21495919)
21. Multiplex RT-PCR for the detection of common BCR-ABL fusion transcripts in paraffin-embedded tissues from patients with chronic myeloid leukemia and acute lymphoblastic leukemia.
Bock O; Reising D; Kreipe H
Diagn Mol Pathol; 2003 Sep; 12(3):119-23. PubMed ID: 12960692
[TBL] [Abstract][Full Text] [Related]
22. Characteristic patterns of HOX gene expression in different types of human leukemia.
Celetti A; Barba P; Cillo C; Rotoli B; Boncinelli E; Magli MC
Int J Cancer; 1993 Jan; 53(2):237-44. PubMed ID: 7678830
[TBL] [Abstract][Full Text] [Related]
23. Three hematologic malignancies in the same patient: chronic lymphocytic leukemia, followed by chronic myeloid leukemia and acute myeloid leukemia.
Fattizzo B; Radice T; Cattaneo D; Pomati M; Barcellini W; Iurlo A
Clin Lab; 2014; 60(11):1929-32. PubMed ID: 25648037
[TBL] [Abstract][Full Text] [Related]
24. Progress and Prospects in Pediatric Leukemia.
Madhusoodhan PP; Carroll WL; Bhatla T
Curr Probl Pediatr Adolesc Health Care; 2016 Jul; 46(7):229-241. PubMed ID: 27283082
[TBL] [Abstract][Full Text] [Related]
25. Malignant transformation by abl and BCR/ABL.
Van Etten RA
Cancer Treat Res; 1992; 63():167-92. PubMed ID: 1363357
[No Abstract] [Full Text] [Related]
26. Rearrangement of immunoglobulin and T cell receptor genes in acute and chronic leukaemias.
Liang R; Chan VV; Chan TK; Chiu E; Todd D
Acta Haematol; 1991; 85(2):71-5. PubMed ID: 1850943
[TBL] [Abstract][Full Text] [Related]
27. Expression of complement regulatory proteins CR1, DAF, MCP and CD59 in haematological malignancies.
Guc D; Canpinar H; Kucukaksu C; Kansu E
Eur J Haematol; 2000 Jan; 64(1):3-9. PubMed ID: 10680700
[TBL] [Abstract][Full Text] [Related]
28. Association of KIR2DS4 and its variant KIR1D with leukemia.
Giebel S; Nowak I; Wojnar J; Krawczyk-Kulis M; Holowiecki J; Kyrcz-Krzemien S; Kusnierczyk P
Leukemia; 2008 Nov; 22(11):2129-30; discussion 2130-1. PubMed ID: 18463675
[No Abstract] [Full Text] [Related]
29. bcr/abl mRNA in leukemic blasts of an unusual patient with acute lymphoblastic leukemia followed after 5-year remission by chronic myelogenous leukemia in blast crisis.
Fujie H; Tsuchiya S; Morita S; Itano M; Yambe T; Ohasi Y; Minegishi N; Minegishi M; Satou T; Konno T
Leukemia; 1994 Sep; 8(9):1592-5. PubMed ID: 8090037
[TBL] [Abstract][Full Text] [Related]
30. Analysis of Four Types of Leukemia Using Gene Ontology Term and Kyoto Encyclopedia of Genes and Genomes Pathway Enrichment Scores.
Lu J; Zhang Y; Wang S; Bi Y; Huang T; Luo X; Cai YD
Comb Chem High Throughput Screen; 2020; 23(4):295-303. PubMed ID: 30599106
[TBL] [Abstract][Full Text] [Related]
31. p190 BCR-ABL rearrangement in chronic myeloid leukemia and acute lymphoblastic leukemia.
Lemes A; Gómez Casares MT; de la Iglesia S; Matutes E; Molero MT
Cancer Genet Cytogenet; 1999 Aug; 113(1):100-2. PubMed ID: 10459357
[TBL] [Abstract][Full Text] [Related]
32. Leukemia and myelomatosis.
Catovsky D
Cancer Chemother Biol Response Modif; 1987; 9():134-64. PubMed ID: 3079401
[No Abstract] [Full Text] [Related]
33. [Ph1-positive leukemia: cytogenetic outline and prognosis].
Misawa S
Nihon Rinsho; 1992 Jun; 50(6):1274-80. PubMed ID: 1518145
[TBL] [Abstract][Full Text] [Related]
34. [Leukemia].
Schalhorn A
MMW Fortschr Med; 2013 Nov; 155(19):48-52; quiz 53. PubMed ID: 24475671
[No Abstract] [Full Text] [Related]
35. The incidence of submicroscopic deletions in reciprocal translocations is similar in acute myeloid leukemia, BCR-ABL positive acute lymphoblastic leukemia, and chronic myeloid leukemia.
Bacher U; Schnittger S; Kern W; Hiddemann W; Haferlach T; Schoch C
Haematologica; 2005 Apr; 90(4):558-9. PubMed ID: 15820957
[TBL] [Abstract][Full Text] [Related]
36. Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemias.
Burger H; Nooter K; Zaman GJ; Sonneveld P; van Wingerden KE; Oostrum RG; Stoter G
Leukemia; 1994 Jun; 8(6):990-7. PubMed ID: 7911548
[TBL] [Abstract][Full Text] [Related]
37. Identification of masked and variant Ph (complex type) translocations in CML and classic Ph in AML and ALL by fluorescence in situ hybridization with the use of bcr/abl cosmid probes.
Chen Z; Morgan R; Berger CS; Pearce-Birge L; Stone JF; Sandberg AA
Cancer Genet Cytogenet; 1993 Oct; 70(2):103-7. PubMed ID: 8242587
[TBL] [Abstract][Full Text] [Related]
38. Direct relation between BCR-ABL tyrosine kinase activity and cyclin D2 expression in lymphoblasts.
Deininger MW; Vieira SA; Parada Y; Banerji L; Lam EW; Peters G; Mahon FX; Köhler T; Goldman JM; Melo JV
Cancer Res; 2001 Nov; 61(21):8005-13. PubMed ID: 11691826
[TBL] [Abstract][Full Text] [Related]
39. Low frequency of ras oncogene mutations in Philadelphia-positive acute leukemia and report of a novel mutation H61 Leu in a single case.
Urbano-Ispizua A; Gill R; Matutes E; Levi S; Wiedemann LM; Catovsky D; Marshall CJ
Leukemia; 1992 Apr; 6(4):342-6. PubMed ID: 1588796
[TBL] [Abstract][Full Text] [Related]
40. Consistent genetic abnormalities in human cancers as targets for selective therapies.
Clarkson BD
Mt Sinai J Med; 1992 Oct; 59(5):400-4. PubMed ID: 1435835
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
